360° SearchNetwork Hot Spots Trends Time Series

Nexium

Type: Product

Name: Nexium

First reported May 17 2013 - Updated May 17 2013 - 1 reports

Find affordable health insurance in high deductibles, tax-free health savings accounts

A candidate for Kansas Insurance Commissioner says neither government programs nor commercial group health insurance plans are as affordable as tax-free health savings accounts combined with high deductible single insurance policies.Beverly Gossage, who ... [Published Individual.com - May 17 2013]

Entities: Health Insurance, Nexium, Affordable Health Care

First reported May 16 2013 - Updated May 16 2013 - 2 reports

New Resources to Find Affordable Medications

As patients and consumers, we face more and more choices about our health care each year. We all support consumer empowerment in decisions about their care, but consumers don’t always have all the information they need to choose between different prescription ... [Published Prescription Access Litigation (PAL) Project - May 16 2013]

Entities: Drugs, Nexium, Patient

First reported May 16 2013 - Updated May 16 2013 - 1 reports

Daiichi Sankyo Co Ltd

Daiichi Sankyo’s Japan Sales Up 8% After Long-Term Prescription Bans Lifted

Daiichi Sankyo’s 2012 Japan sales were ¥442.5 billion, thanks to prescription limits were lifted for Alzheimer drug Memary (memantine) and PPI Nexium (esomeprazole). ... [Published The Rose Sheet - May 16 2013]

Entities: Daiichi Sankyo Co Ltd, Japan, Esomeprazole, Nexium

First reported May 15 2013 - Updated May 15 2013 - 1 reports

GlaxoSmithKline plc

GlaxoSmithKline’s asthma med among top-selling drugs in U.S.

A GlaxoSmithKline (NYSE: GSK) drug rounds out the top five prescribed medicines in the quarter.The British drug company, which has its North American headquarters in Research Triangle Park, comes in fifth with asthma medicine Advair Diskus.The rest of ... [Published Triangle Business Journal - May 15 2013]

Entities: GlaxoSmithKline plc, Abilify, Cymbalta, Drugs

First reported May 13 2013 - Updated May 14 2013 - 1 reports

Pfizer Inc

Pfizer's Direct-To-Consumer Campaigns: A Model For The Future?

In preparation for a possible split of the company, Pfizer (PFE)Selling Viagra directly to customers from its own website, heavy advertising on television to a mass audience, sidestepping wholesalers in Australia, acquisition of OTC drugs and deals with ... [Published Seeking Alpha - May 13 2013]

Entities: Pfizer Inc, Viagra, Drugs, Nexium, Patient

First reported May 09 2013 - Updated May 09 2013 - 2 reports

Giant Eagle Inc

Roundup: Giant Eagle sues drug makers over generics; Fed says mistakes made in mortgage settlement; more

Giant Eagle Inc. claims in a federal antitrust lawsuit filed Wednesday in Pittsburgh that AstraZeneca LP and three generic drug makers conspired to delay the availability of generic versions of Nexium so that the London-based company could maximize its ... [Published Pittsburgh Tribune Review - May 09 2013]

Entities: Giant Eagle Inc, Mortgages, Jacob Lew

First reported May 07 2013 - Updated May 07 2013 - 1 reports

Tamiflu Leads Q1 Drug Sales Growth

In the first quarter of 2013, the rankings for the top five drugs by sales shifted a bit, but exhibited positive growth for the quarter, according to a report released by Drugs.com. Abilify, Otsuka's second generation antipsychotic, and Nexium, AstraZeneca's ... [Published Pharmaceutical Technology - May 07 2013]

Entities: Tamiflu, Drugs, Avonex, Modafinil, Abilify

First reported May 06 2013 - Updated May 06 2013 - 2 reports

Rough U.S. Flu Season Boosts Numbers for Tamiflu

Posted in News, Tamiflu, Influenza, Seasonal InfluenzaDrugs.com, a leading online clinical drug resource, today released first quarter 2013 U.S. prescription sales data for the top 100 drugs. The top five drugs have minor shifts in rank but exhibit ... [Published Infection Control Today - May 06 2013]

Entities: Tamiflu, Influenza, Cymbalta, Drugs

First reported May 01 2013 - Updated May 01 2013 - 1 reports

NEXIUM (Esomeprazole Magnesium) Capsule, Delayed Release [Cardinal Health]

Updated Date: May 1, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - May 01 2013]

Entities: Esomeprazole, Cardinal Health Inc, Nexium

First reported Apr 30 2013 - Updated Apr 30 2013 - 1 reports

How Big Pharma Is Killing Americans

Each year, millions of Americans are dealt the devastating news that they have cancer, and each year, millions of Americans, many of whom are uninsured, have to figure out how to pay for the life-saving treatments that they need.And unfortunately, that ... [Published Care2 - Apr 30 2013]

Entities: Big Pharma, Drugs, Nexium, Medicare, Lipitor

First reported Apr 28 2013 - Updated Apr 28 2013 - 1 reports

WI #12 -- Down .4 lbs

So, this week's WI was a bit of a dissapointment. But, this is exactly why the scale should not be the only measure we go by during weight loss. I worked out and earned activity points every day this week. I tracked all of my foods. But, the scale didn't ... [Published Weight Watchers - Apr 28 2013]

Entities: Nexium, Dieting, Weight Loss

First reported Apr 25 2013 - Updated Apr 25 2013 - 3 reports

AstraZeneca Q1 Earnings: Profit Fell 25 Percent On Generics

AstraZeneca Plc (ADR) (NYSE:AZN) posted Q1 quarter results today and sales missed analysts estimates owing to increased competition from generic versions while earnings beat the consensus.Revenue for the U.K.’s second- biggest pharmaceutical company was ... [Published Value Walk - Apr 25 2013]

Entities: AstraZeneca PLC, Drugs, Brilinta, New York Stock Exchange, GlaxoSmithKline plc

Quotes

ALEXANDRIA, Va. (Logo: http://photos.prnewswire.com/prnh/20100106/DC33253LOGO) "Officials with Medicare and MedPAC, 16 U S Senators and more than 30 U S Representatives have all expressed concerns with Medicare preferred pharmacy drug plans and for good reason. They create access concerns for some patients and may be increasing costs for Medicare and taxpayers. "First, in rural areas seniors in these plans may have to travel 20 miles or more to obtain their prescription drugs. Independent community pharmacists in these areas report that patients are repeatedly dealing with this barrier to obtaining their medications. Perhaps reflecting this problem, more than one million seniors are either very dissatisfied or somewhat dissatisfied with their preferred pharmacy Medicare drug plan[1]. "Second, Medicare and taxpayers may not realize any overall savings from these prescription drug plans (or PDPs). As Medicare said in its proposed 2014 call letter, ' We have begun to scrutinize Part D drug costs in PDPs with preferred networks, and comparing these to costs in the non-preferred networks, as well as to costs in PDPs without preferred networks. We are concerned because our initial results suggest that aggregate unit costs weighted by utilization (for the top 25 brand and top 25 generic drugs) may be higher in preferred networks than in non-preferred networks in some plans [emphasis added] . Combined with lower cost sharing, we believe these higher unit costs may violate the requirement not to increase payments to such plans.' "An analysis by NCPA staff backs up Medicare's concerns. NCPA staff looked at four common drugs (generic version of Lipitor?atorvastatin calcium Tab 20mg 90 day supply; generic version of Plavix?clopidogrel Tab 75mg 90 day supply; Diovan?Tab 80mg 90 day supply; and Nexium?Cap 40mg 90 day supply) on Medicare's Plan Finder website. Looking at two large preferred pharmacy plans (AARP MedicareRx Preferred and Humana Walmart Preferred Rx), the cost of the drugs was compared between preferred pharmacies, mail order pharmacies and non-preferred pharmacies in eight cities ( Helena, MT "There is an easy solution to address the concerns of more than one million seniors with preferred pharmacy drug plans. Allow any legitimate pharmacy willing to accept plan terms and conditions, including reimbursement, to participate. Medicare officials have already recommended this change. In its final 'call letter' for 2014, the agency said it believes that the best way to encourage price competition and to lower costs is to allow any willing pharmacy to participate in preferred networks. We hope that Part D plans will take that suggestion to heart." The National Community Pharmacists Association (NCPA$) represents the interests of America's community pharmacists, including the owners of more than 23,000 independent community pharmacies. Together they represent an $88.5 billion"

Poll: Over One Million Seniors Have Problems With Medicare 'Preferred Pharmacy' Drug Plans [Published TheStreet.com - 17 hours ago]

Although AstraZeneca have not given any specific growth forecasts and timings, they did however say, "Based on our focused investment in key growth platforms and our pipeline, we believe we can significantly exceed current market consensus for 2018 revenues of $21.5 billion." Allocation of cash flow to value creating business will continue and develop through acquisitions and return cash through share repurchases if no suitable...

AstraZeneca: A Dividend Payer With An Attractive Growth Prospect [Published Seeking Alpha - 21 hours ago]

A similar bill in Kansas would "allow carriers to write policies that don't necessarily include all of the mandates. That helps people have lower cost options" Gossage said. Consumers would pick and choose benefits provided

Find affordable health insurance in high deductibles, tax-free health savings accounts [Published Individual.com - May 17 2013]

Depta J, et al "Clinical outcomes associated with proton pump inhibitor use among clopidogrel-treated patients within CYP2C19 genotype groups following acute myocardial infarction in TRIUMPH" SCAI 2013; Abstract A-064

Genes a Part of PPI-Clopidogrel Interaction [Published MedPage Today - May 14 2013]

More Content

sort by: Date \| Relevance
Poll: Over One Million Seniors Have Problems Wi... [Published TheStreet.com - 17 hours ago]
AstraZeneca: A Dividend Payer With An Attractiv... [Published Seeking Alpha - 21 hours ago]
Apple releases update to iTunes, improves Songs... [Published News From Bangladesh - May 19 2013]
Drug Discovery News: Facing the Patent Cliff He... [Published Baker Botts - May 17 2013]
Find affordable health insurance in high deduct... [Published Individual.com - May 17 2013]
US Embassy, USAID Will Attend 14th Conference o... [Published Hondurasweekly - May 17 2013]
Crime rate drops [Published Kelowna Daily Courier - May 17 2013]
Five Drugs in Your Medicine Cabinet that May be... [Published Positive Health - May 17 2013]
New Resources to Find Affordable Medications [Published Prescription Access Litigation (PAL) Project - May 16 2013]
New Resources to Find Affordable Medications [Published Postscript - May 16 2013]
Concerned about GMOs [Published Kelowna Daily Courier - May 16 2013]
Daiichi Sankyo’s Japan Sales Up 8% After Long-T... [Published The Rose Sheet - May 16 2013]
Daiichi Sankyo’s Japan Sales Up 8% After Long-T... [Published BioPortfolio - May 16 2013]
NDP blew their chance [Published Kelowna Daily Courier - May 16 2013]
Genevieve A. Voigt [Published Ozaukee Press - May 16 2013]
Jennifer L. Lemke-Rude [Published Ozaukee Press - May 16 2013]
Jean Lange [Published Ozaukee Press - May 16 2013]
Jerome H. Kroeger [Published Ozaukee Press - May 16 2013]
Ed Burmeister [Published Ozaukee Press - May 16 2013]
Tyler Bares [Published Ozaukee Press - May 16 2013]
MD Introduces the World’s Fastest Notebook Grap... [Published AMD Zone - May 15 2013]
AMD Recognizes Exemplary Performance of Seven S... [Published AMD Zone - May 15 2013]
AMD Expands Never Settle Bundle Crysis 3 and To... [Published AMD Zone - May 15 2013]
GlaxoSmithKline’s asthma med among top-selling ... [Published Triangle Business Journal - May 15 2013]
Daiichi Sankyo's net jumps to Â¥66.6 bn in FY'1... [Published PharmaBiz - May 15 2013]
Council tells residents ditches are up to them [Published Kelowna Daily Courier - May 15 2013]
Facing the patent cliff head-on [Published Drug Discovery News - May 15 2013]
Sony Hardware BS Continues [Published AMD Zone - May 14 2013]
Local candidates make one last push for votes [Published Kelowna Daily Courier - May 14 2013]
Genes a Part of PPI-Clopidogrel Interaction [Published MedPage Today - May 14 2013]

Blogs

sort by: Date \| Relevance
New Resources to Find Affordable Medications [Published Prescription Access Litigation (PAL) Project - May 16 2013] As patients and consumers, we face more and more choices about our health care each year. We all support consumer empowerment in decisions about their care, but consumers don’t always have all the information they need to choose between different prescription ...
New Resources to Find Affordable Medications [Published Postscript - May 16 2013] As patients and consumers, we face more and more choices about our health care each year. We all support consumer empowerment in decisions about their care, but consumers don’t always have all the information they need to choose between different prescription ...
NEXIUM (Esomeprazole Magnesium) Capsule, Delaye... [Published DailyMed Drug Label Updates for the last seven ... - May 01 2013] Updated Date: May 1, 2013 EST ...
Action Alert: Stop the #RxRacket! [Published Prescription Access Litigation (PAL) Project - Apr 09 2013] TAKE ACTION FOR LOWER DRUG COSTS! HELP SPREAD THE WORD Consumer Catalyst has launched a social media campaign to raise awareness about how sketchy ‘Pay-for-Delay’ deals hurt consumer health! Join the discussion on twitter and share your story, using ...
Another Blow To AstraZeneca: S&P Lowers Its Out... [Published Pharmalot - Apr 09 2013] Three weeks ago, Pascal Soirot unveiled a months-long effort to rebuild AstraZeneca, which he joined last fall as ceo amid a disheartening lack of new drugs and increased generic competition. His plan revolves around consolidating R&D and global marketing ...

Press Releases

sort by: Date \| Relevance
Research and Markets: Portugal Debt Crisis Stra... [Published Business Wire - Apr 19 2013]
If You Purchased or Paid for the Drug NEXIUM® (... [Published PR Newswire: Policy & Public Interest - Apr 02 2013]
Drugs.com Releases Q4 Sales for Top 100 U.S. Drugs [Published PR Newswire: Business Technology - Feb 13 2013]
Amneal Partners with Hanmi to Market Nexium® Al... [Published EON Health & Medicine - Jan 28 2013]
Amneal Partners with Hanmi to Market Nexium® Al... [Published EON Business - Jan 28 2013]